Delivery Order SPE2DB20D2104-SPE2DB24FV22T
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,776.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,936 units of the medication Glipizide ER 10 mg tablet, with a completion date of April 17, 2025. This contract is a delivery order, with a firm fixed-price pricing type, and is not a set-aside award. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This is a delivery order worth $5,611.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The order is for the supply of 4,565,318 units of Glipizide ER 10 mg tablets, a prescription medication. The contract has an ultimate completion date of August 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award, valued at $1,806.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glipizide ER 5 mg Tablets in quantities of 1,000 tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 10, 2024. This award does not utilize any set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,840.94 firm-fixed-price delivery order is for the supply of 4,564,996,919 units of the drug Glipizide ER 5 mg tablets. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,514.11, is for the supply of 4566825852 - GLIPIZIDE ER 10 MG TABLET 500S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 3, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. In addition to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,804.22, is for the delivery of 1,000 units of the medication Glipizide ER 10 mg tablet. This is a firm fixed-price delivery order contract with a completion date of February 16, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,759.59, is for the delivery of 4,565,177,703 units of the medication Glipizide ER 10 mg tablet. The contract has an ultimate completion date of July 18, 2024 and is a firm fixed-price type contract. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,396.23, is for the delivery of 4,567,909,357 tablets of Glipizide ER 5 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $5,567.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GLIPIZIDE ER 10 MG TABLET 500S, a generic medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of May 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Glipizide ER 5 mg tablets. The fixed-price delivery order, valued at $1,360.48, has an ultimate completion date of August 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000...